Taking BAFIERTAM

Whether this is your first multiple sclerosis therapy or the next step in your treatment journey, BAFIERTAM® (monomethyl fumarate) delayed-release capsules offers established efficacy and a well-understood safety profile. Both healthcare providers and patients appreciate that treatment with BAFIERTAM is free from dietary restrictions.1

Not actual patient

Here's what you need to know to get started.
Laboratory testing

Before starting treatment with BAFIERTAM, your healthcare provider will likely perform tests to check your liver function and undertake a complete blood count (CBC). This will include a lymphocyte count to check for infection or a blood disorder. Even if you are already taking another fumarate, you may still need a blood test. After starting treatment with BAFIERTAM, you can expect regular blood tests to track its safety.1

Magenta dash icon.
The first follow-up CBC is six months after starting BAFIERTAM.
Magenta dash icon.
Expect additional CBCs every six to 12 months after that and as clinically indicated, as determined by your healthcare provider.
Magenta dash icon.
Your healthcare provider may also perform additional blood tests to check your liver, as needed.1
Dosing schedule
Magenta dash icon.
At first, your healthcare provider will likely start you on half the dose—just one 95 mg capsule―taken orally, twice a day, for seven days.1
Magenta dash icon.
After seven days, your healthcare provider will likely increase the dosage to two 95 mg capsules (190 mg), twice a day.1
BAFIERTAM can be taken with or without food and has no food/alcohol restrictions.1
Important tips for taking BAFIERTAM
White number 1 centered inside a solid magenta circle icon.

Swallow BAFIERTAM capsules whole and intact.

White number 2 centered inside a solid magenta circle icon.

Do not crush, chew, or mix the contents with food.

White number 3 centered inside a solid magenta circle icon.

If you take too much BAFIERTAM, call your healthcare provider or go to the nearest hospital emergency room right away.

Always take BAFIERTAM exactly as your healthcare provider has prescribed it.
Get started on BAFIERTAMFind support with BAFIERTAM
References

1. BAFIERTAM. Prescribing Information. Banner Life Sciences LLC.

Indication and Important Safety Information
Indication and Important Safety Information
Indications

BAFIERTAM® (monomethyl fumarate) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It is not known if BAFIERTAM is safe and effective in children.

Important Safety Information

  • Do not take BAFIERTAM if you have had an allergic reaction (such as welts, hives, swelling of the face, lips, mouth or tongue, or difficulty breathing) to monomethyl fumarate, dimethyl fumarate, diroximel fumarate, or any of the ingredients in BAFIERTAM.
  • Do not take BAFIERTAM if you are taking dimethyl fumarate or diroximel fumarate.

Before taking and while you take BAFIERTAM, tell your Healthcare Provider about all your medical conditions, including if you:

  • have liver problems.
  • have or have had low white blood cell counts or an infection.
  • are pregnant or plan to become pregnant. It is not known if BAFIERTAM will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if BAFIERTAM passes into breast milk. Talk to your healthcare provider about the best way to feed your baby while using BAFIERTAM.

Tell your Healthcare Provider about all other medicines you take including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Serious Adverse Reactions:

BAFIERTAM may cause serious side effects, including:

Allergic reactions (such as welts, hives, swelling of the face, lips, mouth or tongue, or difficulty breathing). Stop taking BAFIERTAM and get emergency medical help right away if you get any of these symptoms.

PML (progressive multifocal leukoencephalopathy) a rare brain infection that usually leads to death or severe disability over a period of weeks or months. Contact your Healthcare provider right away if you if you notice new or worsening symptoms such as weakness on one side of the body, vision problems, trouble thinking, or changes in memory or personality. Your healthcare provider may stop BAFIERTAM if PML is suspected. Increased risk of serious infections, including shingles (herpes zoster) and central nervous system infections.

Decrease in your white blood cell count Your healthcare provider will do a blood test to check your white blood cell count before you start treatment with BAFIERTAM and while you are on therapy. You should have blood tests after 6 months of treatment and every 6 to 12 months after that.

Liver problems. BAFIERTAM may cause serious liver problems that may lead to liver failure, a liver transplant, or death. Blood tests will be done before and during treatment to check your liver. Tell your healthcare provider right away if you have symptoms such as unusual tiredness, loss of appetite, dark urine, yellowing of your skin or eyes, or stomach pain. BAFIERTAM may be stopped if liver injury is suspected.

Flushing: BAFIERTAM may cause flushing, which can feel like warmth, redness, itching, or a burning sensation, usually on the face or upper body. Flushing often starts soon after beginning treatment and usually improves or goes away over time. Most flushing reactions are mild to moderate, but some people have stopped treatment because of flushing.

Tell your healthcare provider if flushing is bothersome or does not improve.

Serious Stomach and Intestinal Problems: Serious stomach and intestinal problems have been reported with medicines like BAFIERTAM. These problems can include severe stomach pain, ulcers, bleeding, blockage, or tears in the stomach or intestines, and in rare cases can be fatal. Serious stomach problems have occurred most often within the first 6 months of treatment.

Call your healthcare provider right away if you have new or worsening severe stomach pain, vomiting, blood in your stool, black stools, or other severe stomach symptoms. Your healthcare provider may stop BAFIERTAM if serious stomach problems occur.

Common Adverse Reactions:

The most common side effects of BAFIERTAM include:

  • Flushing, which may feel like warmth, redness, itching, or a burning sensation.
  • Stomach‑related problems, such as nausea, vomiting, diarrhea, stomach pain, and indigestion.
  • Skin reactions, including rash or itching.

These side effects were most common early in treatment and often became less frequent over time.

Other side effects reported after the medicine became available include hair thinning or hair loss. These are not all the possible side effects of BAFIERTAM. Call your healthcare provider for medical advice about side effects.

For more detailed information, please refer to the full Prescribing Information here.

To report SUSPECTED ADVERSE REACTIONS, contact Banner Life Sciences toll free at phone: 1-866-MMF-95MG, or the FDA at: 1-800-FDA-1088 or www.fda.gov/medwatch.

Dark and mid blue shape divider.
BAFIERTAM logo.
Contact Us

www.cyclepharma.com

www.cyclevita.life

#CycleVitaUSA

#CycleVitaUSA

@cycle-pharmaceuticals

BAFIERTAM® is a registered trademark of Banner Life Sciences, LLC, a Cycle Pharmaceuticals company.
Cycle Vita™ is a trademark of Cycle Pharmaceuticals Limited in the United States.

© 2026 Cycle Pharmaceuticals Limited. All rights reserved.

Compliance & PoliciesAccessibility StatementModern Slavery Statement

US-MMF-2600137 | July 2026